日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab

一项随机 II 期临床试验,旨在评估使用高剂量利沙珠单抗治疗中重度斑块状银屑病患者的疗效。

Blauvelt, Andrew; Jiang, Rundong; Shi, Linyu; Tsoi, Lam C; Bogle, Rachael; Fox, Jennifer; Gharaee-Kermani, Mehrnaz; Billi, Allison C; Matheson, Robert T; Photowala, Huzefa; Gudjonsson, Johann E; Ehst, Benjamin D

A comprehensive study of AAV tropism across C57BL/6 mice, BALB/c mice, and crab-eating macaques

对C57BL/6小鼠、BALB/c小鼠和食蟹猴的AAV嗜性进行全面研究

Fang, Kailun; Yang, Xiali; Liu, Yuanhua; Xia, Junhui; Wu, Ruoxi; Yang, Fan; Feng, Canbin; Liu, Xinyu; Shi, Linyu; Geng, Guannan; Yang, Hui

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies

利沙珠单抗在银屑病关节炎中 GRAPPA 各领域疗效:来自 3 期 KEEPsAKE 1 和 2 研究的汇总分析

Coates, Laura C; Blanco, Ricardo; Behrens, Frank; Ogdie, Alexis; Van den Bosch, Filip; Ranza, Roberto; Klionsky, Yael; Soliman, Ahmed M; Chen, Michael; Coombs, Derek; Shi, Linyu; Urbanik, Jamie R; Iyile, Thomas; Lippe, Ralph; Gossec, Laure

Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials

利用机器学习分析方法,结合两项 3 期临床试验中未接受过生物制剂 DMARD 治疗的患者数据,评估了 Risankizumab 对不同 PsA 表型的疗效

Gossec, Laure; Balanescu, Andra; D'Agostino, Maria Antonietta; Ogdie, Alexis; Sewerin, Philipp; Deng, Yu; Shi, Linyu; Sugimoto, Yoshiyuki; Zhong, Sheng; Xing, Yunzhao; Lippe, Ralph; Kishimoto, Mitsumasa

Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient Survey

患者自主设定的银屑病治疗目标:一项美国患者调查的结果

Armstrong, April; Levit, Noah A; Schneider, Beth; Seiden, Richard; Shi, Linyu; Kaplan, Blair; Wu, Jashin J

Assessment of inverse publication bias in safety outcomes: an empirical analysis

安全性结果中逆向发表偏倚的评估:一项实证分析

Xing, Xing; Zhu, Jianan; Shi, Linyu; Xu, Chang; Lin, Lifeng

A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis

对不同种族和民族的中重度银屑病患者群体中利沙珠单抗的疗效和安全性进行描述性事后分析

Alexis, Andrew F; Gooderham, Melinda; Kwatra, Shawn G; Amin, Ahmad; Taylor, Susan; Espaillat, Ramon; Rettig, Trisha; Wu, Tianshuang; Shi, Linyu; Kaldas, Mark I; Dilley, Deanne M; Sinvhal, Ranjeeta; Nduaka, Chudy; Lockshin, Benjamin

Body fluids should be identified before estimating the time since deposition (TsD) in microbiome-based stain analyses for forensics

在法医微生物组污渍分析中,应先鉴定体液,然后再估算沉积时间(TsD)。

Zhang, Jun; Yu, Daijing; Wang, Tian; Gao, Niu; Shi, Linyu; Wang, Yaya; Huo, Yumei; Ji, Zhimin; Li, Junli; Zhang, Xiaomeng; Zhang, Liwei; Yan, Jiangwei

Self-appreciation is not enough: exercise identity mediates body appreciation and physical activity and the role of perceived stress

自我欣赏还不够:运动认同感调节身体欣赏和身体活动,以及感知压力的作用

Shi, Linyu; Jiang, Lixia; Zhou, Song; Zhou, Wenbo; Yang, Huaqi

Methods for assessing inverse publication bias of adverse events

评估不良事件逆向发表偏倚的方法

Xing, Xing; Xu, Chang; Al Amer, Fahad M; Shi, Linyu; Zhu, Jianan; Lin, Lifeng